Cargando…

Constrained Bithiazoles: Small Molecule Correctors of Defective ΔF508–CFTR Protein Trafficking

[Image: see text] Conformationally constrained bithiazoles were previously found to have improved efficacy over nonconstrained bithiazoles for correction of defective cellular processing of the ΔF508 mutant cystic fibrosis transmembrane conductance regulator (CFTR) protein. In this study, two sets o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coffman, Keith C., Nguyen, Huy H., Phuan, Puay-Wah, Hudson, Brandi M., Yu, Gui J., Bagdasarian, Alex L., Montgomery, Deanna, Lodewyk, Michael W., Yang, Baoxue, Yoo, Choong L., Verkman, A. S., Tantillo, Dean J., Kurth, Mark J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2014
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136667/ https://www.ncbi.nlm.nih.gov/pubmed/25061695 http://dx.doi.org/10.1021/jm5007885

Ejemplares similares

Bithiazole Correctors Rescue CFTR Mutants by Two Different Mechanisms
por: Loo, Tip W., et al.
Publicado: (2013)

Correctors modify the bicarbonate permeability of F508del-CFTR
por: Fiore, Michele, et al.
Publicado: (2020)

Bioactive Thymosin Alpha-1 Does Not Influence F508del-CFTR Maturation and Activity
por: Armirotti, Andrea, et al.
Publicado: (2019)

Synthesis and Evaluation of Bithiazole Derivatives As Potential α-Sarcoglycan Correctors
por: Ribaudo, Giovanni, et al.
Publicado: (2023)

Extracellular phosphate enhances the function of F508del-CFTR rescued by CFTR correctors
por: Saint-Criq, Vinciane, et al.
Publicado: (2021)

Functional Rescue of F508del-CFTR Using Small Molecule Correctors
por: Molinski, Steven, et al.
Publicado: (2012)

Partial Rescue of F508del-CFTR Stability and Trafficking Defects by Double Corrector Treatment
por: Capurro, Valeria, et al.
Publicado: (2021)

Discovery of novel potent ΔF508-CFTR correctors that target the nucleotide binding domain
por: Odolczyk, Norbert, et al.
Publicado: (2013)

Molecular Docking and QSAR Studies as Computational Tools Exploring the Rescue Ability of F508del CFTR Correctors
por: Righetti, Giada, et al.
Publicado: (2020)

Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors
por: Amico, Giulia, et al.
Publicado: (2019)

Small molecule correctors divert CFTR-F508del from ERAD by stabilizing sequential folding states
por: Riepe, Celeste, et al.
Publicado: (2023)

Pharmacological Correctors of Mutant CFTR Mistrafficking
por: Pedemonte, Nicoletta, et al.
Publicado: (2012)

Targeting protein–protein interactions to rescue Δf508-cftr: a novel corrector approach to treat cystic fibrosis
por: Devesa, Isabel, et al.
Publicado: (2013)

Nanomolar-potency ‘co-potentiator’ therapy for cystic fibrosis caused by a defined subset of minimal function CFTR mutants
por: Phuan, Puay-Wah, et al.
Publicado: (2019)

Potential Therapeutic Benefit of C1-Esterase Inhibitor in Neuromyelitis Optica Evaluated In Vitro and in an Experimental Rat Model
por: Tradtrantip, Lukmanee, et al.
Publicado: (2014)

CFTR Activator Increases Intestinal Fluid Secretion and Normalizes Stool Output in a Mouse Model of Constipation
por: Cil, Onur, et al.
Publicado: (2016)

Production of CFTR-ΔF508 Rabbits
por: Yang, Dongshan, et al.
Publicado: (2021)

Defective Fluid Secretion from Submucosal Glands of Nasal Turbinates from CFTR(-/-) and CFTR(ΔF508/ΔF508) Pigs
por: Cho, Hyung-Ju, et al.
Publicado: (2011)

Recovery of ΔF508-CFTR Function by Citrate
por: Borkenhagen, Beatrice, et al.
Publicado: (2022)

Journey on VX-809-Based Hybrid Derivatives towards Drug-like F508del-CFTR Correctors: From Molecular Modeling to Chemical Synthesis and Biological Assays
por: Parodi, Alice, et al.
Publicado: (2022)

Characterization of Nasal Potential Difference in cftr Knockout and F508del-CFTR Mice
por: Saussereau, Emilie Lyne, et al.
Publicado: (2013)

Evaluation of Fused Pyrrolothiazole Systems as Correctors of Mutant CFTR Protein
por: Spanò, Virginia, et al.
Publicado: (2021)

NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic Fibrosis
por: Brandas, Chiara, et al.
Publicado: (2021)

Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation
por: Stefano, Daniela De, et al.
Publicado: (2014)

Benzbromarone Stabilizes ΔF508 CFTR at the Cell Surface
por: Loo, Tip W., et al.
Publicado: (2011)

In vivo model for modulators of CFTR(ΔF508) misfolding
Publicado: (2012)

Lipid-driven CFTR clustering is impaired in cystic fibrosis and restored by corrector drugs
por: Abu-Arish, Asmahan, et al.
Publicado: (2022)

Therapeutic Potential for CFTR Correctors in Autosomal Recessive Polycystic Kidney Disease
por: Yanda, Murali K., et al.
Publicado: (2021)

Discovery of a picomolar potency pharmacological corrector of the mutant CFTR chloride channel
por: Pedemonte, Nicoletta, et al.
Publicado: (2020)

Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel
por: Renda, Mario, et al.
Publicado: (2023)

CFTR-F508 pigs provide new clues to cystic fibrosis
Publicado: (2011)

Syntaxin 8 and the Endoplasmic Reticulum Processing of ΔF508-CFTR
por: Sabirzhanova, Inna, et al.
Publicado: (2018)

Structural Comparative Modeling of Multi-Domain F508del CFTR
por: McDonald, Eli Fritz, et al.
Publicado: (2022)

Variable Responses to CFTR Correctors in vitro: Estimating the Design Effect in Precision Medicine
por: Matthes, Elizabeth, et al.
Publicado: (2018)

Combination of Correctors Rescues CFTR Transmembrane-Domain Mutants by Mitigating their Interactions with Proteostasis
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2017)

Computational Exploration of Potential CFTR Binding Sites for Type I Corrector Drugs
por: Lester, Anna, et al.
Publicado: (2023)

Is CFTR-delF508 Really Absent from the Apical Membrane of the Airway Epithelium?
por: Borthwick, Lee A., et al.
Publicado: (2011)

Full Rescue of F508del-CFTR Processing and Function by CFTR Modulators Can Be Achieved by Removal of Two Regulatory Regions
por: Uliyakina, Inna, et al.
Publicado: (2020)

Unravelling druggable signalling networks that control F508del-CFTR proteostasis
por: Hegde, Ramanath Narayana, et al.
Publicado: (2015)

Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis
por: Esposito, Speranza, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_oa28vkkir59cbtbolf77vpgtjn